0000899243-22-031692.txt : 20220922
0000899243-22-031692.hdr.sgml : 20220922
20220922160015
ACCESSION NUMBER: 0000899243-22-031692
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220921
FILED AS OF DATE: 20220922
DATE AS OF CHANGE: 20220922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canaan XI L.P.
CENTRAL INDEX KEY: 0001712417
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40431
FILM NUMBER: 221259223
BUSINESS ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE
STREET 2: SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: 203-855-0400
MAIL ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE
STREET 2: SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canaan Partners XI LLC
CENTRAL INDEX KEY: 0001850694
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40431
FILM NUMBER: 221259222
BUSINESS ADDRESS:
STREET 1: 2765 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 203-855-0400
MAIL ADDRESS:
STREET 1: 2765 SAND HILL ROAD
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Day One Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001845337
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832415215
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BLVD STE 217
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-1930
BUSINESS PHONE: 206-913-4300
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BLVD STE 217
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-1930
FORMER COMPANY:
FORMER CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC
DATE OF NAME CHANGE: 20210209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-09-21
1
0001845337
Day One Biopharmaceuticals, Inc.
DAWN
0001712417
Canaan XI L.P.
285 RIVERSIDE AVENUE, SUITE 250
WESTPORT
CT
06880
0
0
1
0
0001850694
Canaan Partners XI LLC
285 RIVERSIDE AVENUE, SUITE 250
WESTPORT
CT
06880
0
0
1
0
Common Stock
2022-09-21
4
S
0
607497
18.54
D
8470407
D
Common Stock
2022-09-21
4
S
0
6106
19.29
D
8464301
D
Common Stock
2022-09-21
4
J
0
1500000
D
6964301
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.27 - $19.26, inclusive. The Reporting Persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are held directly by Canaan XI L.P. (the "Canaan Fund"). Canaan Partners XI LLC ("Canaan XI") is the sole general partner of the Canaan Fund and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Canaan XI disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.27 - $19.35, inclusive. The Reporting Persons undertake to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On September 21, 2022, the Canaan Fund distributed, for no consideration, 1,500,000 shares of common stock of the issuer to its limited partners and to Canaan XI, the general partner of the Canaan Fund, representing each such partner's pro rata interest in the shares held by the Canaan Fund. On the same date, Canaan XI distributed, for no consideration, the shares it received from the distribution to its members in an amount equal to each such member's pro rata interest in the shares. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
Canaan XI L.P., By: Canaan Partners XI LLC, its general partner, By: /s/ Nancy Levenson, Attorney-in-Fact
2022-09-22
Canaan Partners XI LLC, By: /s/ Nancy Levenson, Attorney-in-Fact
2022-09-22